APA (7th ed.) Citation

Mosbech, H., Deckelmann, R., de Blay, F., Pastorello, E. A., Trebas-Pietras, E., Andres, L. P., . . . Canonica, G. W. (2014). Standardized quality (SQ) house dust mite sublingual immunotherapy tablet (ALK) reduces inhaled corticosteroid use while maintaining asthma control: A randomized, double-blind, placebo-controlled trial. Journal of allergy and clinical immunology, 134(3), 568-575.e7. https://doi.org/10.1016/j.jaci.2014.03.019

Chicago Style (17th ed.) Citation

Mosbech, Holger, Regina Deckelmann, Fréderic de Blay, Elide Anna Pastorello, Ewa Trebas-Pietras, Luis Prieto Andres, Inga Malcus, Christian Ljørring, and Giorgio Walter Canonica. "Standardized Quality (SQ) House Dust Mite Sublingual Immunotherapy Tablet (ALK) Reduces Inhaled Corticosteroid use While Maintaining Asthma Control: A randomized, Double-blind, Placebo-controlled Trial." Journal of Allergy and Clinical Immunology 134, no. 3 (2014): 568-575.e7. https://doi.org/10.1016/j.jaci.2014.03.019.

MLA (9th ed.) Citation

Mosbech, Holger, et al. "Standardized Quality (SQ) House Dust Mite Sublingual Immunotherapy Tablet (ALK) Reduces Inhaled Corticosteroid use While Maintaining Asthma Control: A randomized, Double-blind, Placebo-controlled Trial." Journal of Allergy and Clinical Immunology, vol. 134, no. 3, 2014, pp. 568-575.e7, https://doi.org/10.1016/j.jaci.2014.03.019.